RxDoctor Payments DataLook up a doctor →

Kimberly Robertson

Gerontology · Colorado Springs, CONPI 1407333446

Payments from drug & device makers

$8,526in general payments, 2019–2025

Across 422 payments — averaging $20.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Pfizer$587
  • Livanova USA, Inc.$541
  • Neurocrine Biosciences, Inc.$508
  • AstraZeneca$493
  • UCB, Inc.$415
  • plus $4K from 52 others

What the payments were for

  • Travel & lodging$2683%
  • Food & beverage$8,25897%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,526 in reported general payments places this provider in the 95th percentile of 85 gerontology providers in Colorado.

See all gerontology providers in Colorado

Medicare billing

Part B allowed, 2024
$44,120
Medicare patients
240
Services billed
1,401

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
UbrelvyUbrogepant198$290,490
IngrezzaValbenazine Tosylate15$217,022
QuliptaAtogepant141$182,648
Nurtec OdtRimegepant Sulfate125$146,980
Kesimpta PenOfatumumab12$104,827
BriviactBrivaracetam45$85,915
Emgality PenGalcanezumab-Gnlm105$77,402
Aimovig AutoinjectorErenumab-Aooe43$36,122
AptiomEslicarbazepine Acetate19$23,699
Lacosamide119$14,748
Emgality SyringeGalcanezumab-Gnlm18$13,632
Ajovy SyringeFremanezumab-Vfrm17$13,532
Levetiracetam247$5,946
Gabapentin394$5,469
Pregabalin182$5,183

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieUbrelvy, Qulipta$1,652$473,138339 claims
Neurocrine Biosciences, Inc.Ingrezza$508$217,02215 claims
PfizerNurtec Odt$587$146,980125 claims
UCB, Inc.Briviact$415$85,91545 claims
Upsher-smith Laboratories LLCTopiramate$25$2,522185 claims
Amneal Pharmaceuticals LLCPyridostigmine Bromide$15$1,22321 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 85 gerontology providers in Colorado.

Other gerontology in Colorado Springs

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →